Enovis CORP
ENOVNYSE
$27.07
↓ -3.6%Jul 17 close · end-of-day
Price
1Y↓ -11.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$1.6B
Enterprise Value
$2.8B
P/E
—
P/S
0.7
P/B
1.1
EV/EBITDA
10.3
PEG
—
FCF Yield
2.3%
Dividend Yield
—
Revenue (TTM)
$2.3B
Net Income (TTM)
-$1.1B
Free Cash Flow (TTM)
$35.9M
Gross Margin
60.5%
Operating Margin
-47.0%
Net Margin
-49.9%
ROE
-77.0%
ROIC
-30.6%
Debt / Equity
0.9
Net Cash
-$1.3B
Return 1Y
-12.3%
Company profile
Enovis Corporation develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, and other healthcare professionals. The company sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies.
- CEO
- Matthew L. Trerotola
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 6,800
- Headquarters
- Delaware
- Website
- enovis.com
Management & directors
- Engert OliverChief Administrative Officer
- Berry Phillip Benjamin (Ben)SVP, Chief Financial Officer
- Mcdonald DamienChief Executive Officer
- Kleckner JohnPrincipal Accounting Officer
- Lang Patricia ASVP, Chief HR Officer
- Ross Terry DGROUP PRESIDENT, P&R
- Tandy Bradley JSVP and Chief Legal Officer
- Vogt LouisGROUP PRESIDENT, RECON
- Pryor Daniel AEVP, Strategy & Business Dev.
Roles derived from SEC Form 4 filings.
Earnings
ENOV Q1 2026 Earnings
Period ends 2026-04-03
MetricActualYoY
Revenue$589.2M↑ +5.4%
Diluted EPS-$0.15↓ -84.7%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.4B | $1.6B | $1.7B | $2.1B | $2.2B |
| Gross profit | $603.6M | $777.7M | $869.4M | $990.8M | $1.2B | $1.3B |
| Operating income | -$66.2M | -$62.8M | -$71.2M | -$65.7M | -$775.7M | -$1.1B |
| Net income | $42.6M | $71.7M | -$13.3M | -$33.3M | -$825.5M | -$1.2B |
| Diluted EPS | $0.93 | $1.40 | -$0.25 | -$0.61 | -$14.93 | -$20.75 |
| Operating cash flow | $301.9M | $356.1M | -$55.9M | $135.0M | $113.5M | $217.3M |
| Free cash flow | $187.2M | $251.9M | -$161.3M | $12.8M | -$67.2M | $19.9M |
| Gross margin | 53.9% | 54.5% | 55.6% | 58.0% | 56.0% | 59.8% |
| Operating margin | -5.9% | -4.4% | -4.6% | -3.8% | -36.8% | -50.0% |
| Net margin | 3.8% | 5.0% | -0.9% | -1.9% | -39.2% | -52.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $525.2M | $505.2M | $561.0M | $558.8M | $564.5M | $548.9M | $575.8M | $589.2M |
| Gross profit | $288.9M | $286.5M | $307.5M | $332.2M | $334.7M | $328.9M | $349.4M | $365.5M |
| Operating income | -$44.2M | -$31.7M | -$664.7M | -$46.8M | -$16.8M | -$558.5M | -$502.2M | $6.5M |
| Net income | -$18.6M | -$31.5M | -$703.3M | -$56.0M | -$36.7M | -$571.1M | -$520.6M | -$8.8M |
| Diluted EPS | -$0.34 | -$0.58 | -$12.69 | -$0.98 | -$0.64 | -$9.99 | -$9.14 | -$0.15 |
| Operating cash flow | $7.8M | $53.6M | $88.3M | -$1.6M | $47.8M | $82.6M | $88.5M | $24.0M |
| Free cash flow | -$31.6M | $2.4M | $35.1M | -$44.9M | $3.4M | $29.1M | $32.3M | -$28.9M |
| Gross margin | 55.0% | 56.7% | 54.8% | 59.5% | 59.3% | 59.9% | 60.7% | 62.0% |
| Operating margin | -8.4% | -6.3% | -118.5% | -8.4% | -3.0% | -101.7% | -87.2% | 1.1% |
| Net margin | -3.5% | -6.2% | -125.4% | -10.0% | -6.5% | -104.1% | -90.4% | -1.5% |
Company news
Jul 17, 2026
- 2d agoSTAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Knowfinance.yahoo.com
- 2d agoStocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovisfinance.yahoo.com
- 3d agoEnovis to Host Second Quarter 2026 Results Conference Call on August 6thfinance.yahoo.com
Jul 13, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Ortiz Christine | Award | 846 | $0.00 | $0.00 | filing |
| 2026-06-15 | Engert Oliver· Chief Administrative Officer | Buy | 1,000 | $20.92 | $20,920.00 | filing |
| 2026-06-11 | Engert Oliver· Chief Administrative Officer | Buy | 1,000 | $21.75 | $21,750.00 | filing |
| 2026-06-11 | Engert Oliver· Chief Administrative Officer | Award | 1,000 | $20.99 | $20,990.00 | filing |
| 2026-06-11 | Engert Oliver· Chief Administrative Officer | Buy | 200 | $20.99 | $4,198.00 | filing |
| 2026-06-10 | Engert Oliver· Chief Administrative Officer | Buy | 1,000 | $23.00 | $23,000.00 | filing |
| 2026-06-01 | Engert Oliver· Chief Administrative Officer | Buy | 1,000 | $22.22 | $22,220.00 | filing |
| 2026-05-19 | Kelly Liam | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | Vinnakota Rajiv | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | Wienbar Sharon L | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | Shirley Brady | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | Bodem Barbara W. | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | Okala Philip | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | Ortiz Christine | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | Lalor Angela S | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-19 | PERFALL A CLAYTON | Award | 9,346 | $0.00 | $0.00 | filing |
| 2026-05-12 | McDonald Damien· Chief Executive Officer | Tax withholding | 12,634 | $25.99 | $328,357.66 | filing |
| 2026-05-12 | BERRY PHILLIP BENJAMIN (BEN)· SVP, Chief Financial Officer | Tax withholding | 7,774 | $25.99 | $202,046.26 | filing |
| 2026-03-31 | Ortiz Christine | Award | 770 | $0.00 | $0.00 | filing |
| 2026-03-13 | Engert Oliver· Chief Administrative Officer | Buy | 1,000 | $23.74 | $23,740.00 | filing |
| 2026-03-10 | Engert Oliver· Chief Administrative Officer | Buy | 1,000 | $23.93 | $23,930.00 | filing |
| 2026-03-09 | KLECKNER JOHN· Principal Accounting Officer | Award | 14,925 | $0.00 | $0.00 | filing |
| 2026-03-09 | ROSS TERRY D· GROUP PRESIDENT, P&R | Award | 36,247 | $0.00 | $0.00 | filing |
| 2026-03-09 | Lang Patricia A· SVP, Chief HR Officer | Award | 25,586 | $0.00 | $0.00 | filing |
| 2026-03-09 | VOGT LOUIS· GROUP PRESIDENT, RECON | Award | 36,247 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.